TNF and melanoma: Unfortunately, only in rare cases clinical activity was seen and severe adverse events have been a major hurdle, and to date TNF-α in melanoma is only used as a ‘facilitator’ to increase penetration of chemotherapeutic agents in the settings of single limb perfusion of in-transit metastases (118).